# A Clinical Study of ZL-85FA Tablets

> **NCT07339748** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Chengdu Zenitar Biomedical Technology Co., Ltd** · enrollment: 51 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** ZL-85FA tablets
- **DRUG:** ZL-85FA tablets
- **DRUG:** ZL-85FA tablets
- **DRUG:** ZL-85FA tablets
- **DRUG:** ZL-85FA tablets
- **DRUG:** ZL-85FA tablets
- **DRUG:** ZL-85FA tablets
- **DRUG:** ZL-85FA tablets
- **DRUG:** ZL-85FA tablets

## Key facts

- **NCT ID:** NCT07339748
- **Lead sponsor:** Chengdu Zenitar Biomedical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07339748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07339748, "A Clinical Study of ZL-85FA Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07339748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*